NITI Aayog member (health) Dr V K Paul stated that concerns about adverse effects, as of now, seem to be "unfounded, negligible and insignificant" and the data shows that "we are in a situation of lot of comfort".(PTI )
NITI Aayog member (health) Dr V K Paul stated that concerns about adverse effects, as of now, seem to be "unfounded, negligible and insignificant" and the data shows that "we are in a situation of lot of comfort".(PTI )

Govt says concerns about adverse effect post Covid vaccination unfounded

At a press conference, NITI Aayog member (health) Dr V K Paul asserted that both the vaccines -- Covishield and Covaxin -- are safe and a lot of effort has gone into making them.
PTI
PUBLISHED ON JAN 19, 2021 09:32 PM IST

Urging healthcare workers not to hesitate to get the COVID-19 vaccine, the Centre on Tuesday said it was their societal responsibility to get inoculated, and concerns about adverse effects, as of now, seem to be "unfounded, negligible and insignificant".

At a press conference, NITI Aayog member (health) Dr V K Paul asserted that both the vaccines -- Covishield and Covaxin -- are safe and a lot of effort has gone into making them.

It is saddening that healthcare workers, especially doctors and nurses, are declining to take it, he said.

"We are not fulfilling our societal responsibility if a vaccine assigned to us is not being taken. The whole world is clamouring for a vaccine. I request you to please accept the jab.

"Vaccine hesitancy should extinguish because COVID-19 inoculation is taking us towards the elimination of this calamity," Paul said and disclosed that he himself has taken a jab of Covaxin.

He stated that concerns about adverse effects, as of now, seem to be "unfounded, negligible and insignificant" and the data shows that "we are in a situation of lot of comfort".

"We would like to reassure you with data that you have seen that these two vaccines are safe, they do not excite undue reactogenicity and are being accepted increasingly. They are also highly immunogenic," Paul said.

"We are very fortunate that we are running this vaccination drive at a time when the pandemic looks like to be in a controlled situation. So in this period, by taking the jabs, we have to create a wall of vaccine-induced immunity and be ready for any kind of eventuality in future," he said.

Union Health Secretary Rajesh Bhushan said every country has been facing vaccine hesitancy.

"Probably the degree of it is slightly more in case of COVID-19, not just in India but across countries because it's a new disease, new vaccine and therefore more confusion."

Vaccine hesitancy was seen in case of polio and Measles-rubella, Bhushan said, "The only way of addressing it is by engaging repeatedly with the beneficiary groups and trying to address all their doubts and confusions. That is our advise to all states and Union Territories."

"Good communication, understanding the facts behind it and taking it as a duty for yourself and for the society," Paul supplemented.

About whether a person is liable for compensation in case of an adverse event, Bhushan said, "The vaccine (Covaxin) which has been given emergency use authorisation under clinical trial mode is accompanied by three documents. One is the factsheet which is read out and explained to beneficiaries, second is a consent form... and the third is an adverse event reporting form where the recipient has to report the adverse event for the first seven days.

"There, it is clearly mentioned that if there is a causal relationship between immunisation and the adverse event whether it is severe or serious the hospitalisation costs would be borne by the authorities. That is the position as it exists now," he said.


Bhushan further said in case of Covishield vaccine the monitoring is passive.

"It is that after taking the vaccine I sit for half an hour and I am observed. If there is nothing I go home. If I develop a symptom the onus is on me to come to the hospital and report it. Whereas in case of Covaxin it is active follow-up. The doctor rings you up on a daily basis and you are given a form which you fill for seven days," he said.

On how the vaccines are distributed to states and Union Territories, Bhushan said it is done based on the proportion in which the Centre got the supplies.

"Which vaccine will go to which vaccination session is a decision which has been left entirely to the states. So states have taken a decision," the Union health secretary said. PTI PLB UZM NSD

SHARE THIS ARTICLE ON
Close
A study by the University of Oxford shows AstraZeneca effective against Brazil variant.(AP)
A study by the University of Oxford shows AstraZeneca effective against Brazil variant.(AP)

Covid-19 pandemic: WHO warns against letting guard down

Agencies, Geneva
UPDATED ON MAR 07, 2021 05:37 AM IST
“Countries are going to lurch back into third and fourth surges if we’re not careful.” Mike Ryan, WHO’s top emergency expert, told an online briefing.
Close
In the second phase of the vaccination drive, 3,005,039 people over 60 years of age and 460,782 between 45 and 59 years with comorbidities have received their first dose of the vaccine.(Reuters)
In the second phase of the vaccination drive, 3,005,039 people over 60 years of age and 460,782 between 45 and 59 years with comorbidities have received their first dose of the vaccine.(Reuters)

Cumulative Covid-19 vaccinations cross 20-million mark: Government

By hindustantimes.com | Written by Srivatsan K C, New Delhi
PUBLISHED ON MAR 06, 2021 11:35 PM IST
India has administered 20,662,073 doses of the vaccine so far of which 6,972,859 healthcare workers have received the first dose and 3,522,671 have got the second dose.
Close
Indian Army personnel receives a dose of COVID-19 vaccine at a military hospital in Jabalpur. (PTI Photo)
Indian Army personnel receives a dose of COVID-19 vaccine at a military hospital in Jabalpur. (PTI Photo)

Army veterans to be vaccinated from next week. All you need to know

By hindustantimes.com | Edited by Shankhyaneel Sarkar, Hindustan Times, New Delhi
PUBLISHED ON MAR 06, 2021 11:28 PM IST
  • The government, when it launched its vaccination programme on January 16, ensured that army personnel involved in active duty also get vaccinated as the nation in its first phase had decided to inoculate healthcare workers as well as frontline workers.
Close
Researchers sequenced 750 genomes of the novel coronavirus from infected individuals and analysed mutations for their potential to alter T cell epitopes.(Reuters)
Researchers sequenced 750 genomes of the novel coronavirus from infected individuals and analysed mutations for their potential to alter T cell epitopes.(Reuters)

Study says some coronavirus mutations help it evade T-killer cells

PTI, London
UPDATED ON MAR 06, 2021 04:22 PM IST
In the current study, published in the journal Cell Immunology, the researchers sequenced 750 genomes of the novel coronavirus from infected individuals and analysed mutations for their potential to alter T cell epitopes.
Close
The researchers at the Georgia Institute of Technology and Emory University, US, used the technology to code for a protein called Cas13a that destroys parts of the RNA genetic code which viruses use to replicate in cells in the lungs.(HT Archive/For Representative Purposes Only)
The researchers at the Georgia Institute of Technology and Emory University, US, used the technology to code for a protein called Cas13a that destroys parts of the RNA genetic code which viruses use to replicate in cells in the lungs.(HT Archive/For Representative Purposes Only)

Treatment based on CRISPR can stop replication of Covid-19, flu viruses: Study

PTI, Washington
PUBLISHED ON MAR 05, 2021 04:34 PM IST
The therapy, described in the journal Nature Biotechnology, is based on CRISPR technology, which is normally used to target and edit specific portions of the genetic code -- the way that the four bases of DNA -- A, C, G and T -- are strung together.
Close
The study is the world's largest trial of treatments for hospitalised Covid-19 adults.(Reuters file photo. Representative image)
The study is the world's largest trial of treatments for hospitalised Covid-19 adults.(Reuters file photo. Representative image)

UK Covid-19 trial finds no benefit of gout drug in hospitalised adults

Posted by Harshit Sabarwal | Reuters
PUBLISHED ON MAR 05, 2021 04:06 PM IST
An independent panel suggested pausing recruitment of volunteers in the colchicine arm of the trial based on a preliminary analysis, scientists involved in UK's RECOVERY study said.
Close
The researchers said there is wide variation in how much antibody a person produces in response to vaccination or natural infection.(AP)
The researchers said there is wide variation in how much antibody a person produces in response to vaccination or natural infection.(AP)

Covid-19 antibodies, vaccines less effective against virus variants: Study

Posted by Harshit Sabarwal | PTI, Washington
PUBLISHED ON MAR 05, 2021 02:33 PM IST
The research, published in the journal Nature Medicine, noted that the three fast-spreading variants of the coronavirus first reported in South Africa, the UK and Brazil, can evade antibodies that work against the original form of the virus that sparked the pandemic.
Close
India’s vaccination drive has completed 17,711,287 jabs as of 7pm on Thursday.(HT Photo)
India’s vaccination drive has completed 17,711,287 jabs as of 7pm on Thursday.(HT Photo)

More than 1 million Covid-19 vaccine doses given in a day: Government

By hindustantimes.com | Written by Srivatsan K C, New Delhi
PUBLISHED ON MAR 04, 2021 11:16 PM IST
“Total 10,93,954 vaccine doses were given till 7 pm today, the forty-eighth day of nationwide COVID19 vaccination,” the health ministry said in a statement.
Close
South Africa regulator at 'advanced' stage of Pfizer's Covid-19 vaccine review (Reuters)
South Africa regulator at 'advanced' stage of Pfizer's Covid-19 vaccine review (Reuters)

South Africa regulator at 'advanced' stage of Pfizer Covid-19 vaccine review

Reuters
PUBLISHED ON MAR 04, 2021 10:46 PM IST
According to the South African Health Products Regulatory Authority (SAHPRA), Pfizer's Section 21 application is in advanced stages of review. Such an application, normally valid for six months, is an instrument for emergency use access of a health product that is unregistered.
Close
The isolates or viral samples were recovered from nasal secretions of consenting Covid-19 positive individuals.(Pixabay | Representational image)
The isolates or viral samples were recovered from nasal secretions of consenting Covid-19 positive individuals.(Pixabay | Representational image)

Indian study finds multiple mutations, unique proteins in coronavirus

PTI, Bengaluru
PUBLISHED ON MAR 04, 2021 04:36 PM IST
The study has also shown that the host produces several proteins of their own as their body launches an immunological defence in response to the viral attack.
Close
Canadian company Resverlogix has used the QIMR Berghofer research findings as the basis for expanding its clinical trial of the drug, apabetalone.(Representative image/Bloomberg)
Canadian company Resverlogix has used the QIMR Berghofer research findings as the basis for expanding its clinical trial of the drug, apabetalone.(Representative image/Bloomberg)

Researchers identify cause, potential treatment for Covid-induced heart damage

ANI, Washington
PUBLISHED ON MAR 04, 2021 05:09 AM IST
In severe cases of Covid-19, the immune system overreacts to the infection, releasing inflammatory molecules called cytokines into the bloodstream.
Close
Terezinha da Conceicao, 80, left, and Dulcinea da Silva Lopes, 59, get vaccinated in front of the Christ the Redeemer statue in Rio de Janeiro, Brazil. Data in recent weeks on new variants from South Africa and Brazil has undercut optimism sparked late last year by two vaccines with around 95% efficacy against Covid-19. (AP Photo)
Terezinha da Conceicao, 80, left, and Dulcinea da Silva Lopes, 59, get vaccinated in front of the Christ the Redeemer statue in Rio de Janeiro, Brazil. Data in recent weeks on new variants from South Africa and Brazil has undercut optimism sparked late last year by two vaccines with around 95% efficacy against Covid-19. (AP Photo)

Mutating Covid-19 mars optimism initially brought on by vaccines: Report

Reuters, Chicago
PUBLISHED ON MAR 03, 2021 11:12 PM IST
A new consensus is emerging among scientists, according to Reuters interviews with 18 specialists who closely track the pandemic or are working to curb its impact.
Close
PM Modi, President Kovind, Vice President Naidu, Union minister Harsh Vardhan and eminent Sarod player Ustad Amjad Ali Khan received their first does of Covid-19 vaccine. (HT Photos/Twitter/BeFunkyCollage)
PM Modi, President Kovind, Vice President Naidu, Union minister Harsh Vardhan and eminent Sarod player Ustad Amjad Ali Khan received their first does of Covid-19 vaccine. (HT Photos/Twitter/BeFunkyCollage)

Covid-19 vaccination drive: List of eminent personalities inoculated

By hindustantimes.com | Edited by Shankhyaneel Sarkar, Hindustan Times, New Delhi
UPDATED ON MAR 03, 2021 08:10 PM IST
  • These lawmakers are trying to address vaccine hesitancy which medical experts and lawmakers believe may impact the vaccination drive.
Close
Representational image. (Pratham Gokhale/HT Photo)
Representational image. (Pratham Gokhale/HT Photo)

Covaxin shows 81% efficacy in phase 3 clinical trial: Bharat Biotech

UPDATED ON MAR 04, 2021 03:44 AM IST
The vaccine is stable at 2°C to 8°C (refrigeration) and is shipped in a ready-to-use liquid formulation that permits distribution using existing vaccine supply chain channels
Close
Colorized scanning electron micrograph of an apoptotic cell (greenish brown) heavily infected with SARS-COV-2 virus particles (pink), also known as novel coronavirus, isolated from a patient sample.(Reuters)
Colorized scanning electron micrograph of an apoptotic cell (greenish brown) heavily infected with SARS-COV-2 virus particles (pink), also known as novel coronavirus, isolated from a patient sample.(Reuters)

Study shows how Covid-19 can impact functioning of heart muscles

PTI, Washington
UPDATED ON MAR 03, 2021 02:32 PM IST
The researchers found that viral infection not only kills heart muscle cells but destroys the muscle fibre units responsible for heart muscle contraction.
Close
SHARE
Story Saved
OPEN APP